Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ThreeFold Sensors is a biotechnology company that developed a breakthrough protein detection platform based on electrochemical sensing. The company's technology utilizes a unique 'pendulum' mechanism to achieve high sensitivity and rapid results for protein biomarker analysis. This platform was designed to enable decentralized and high-throughput proteomics, complementing existing genomic workflows. In early 2023, ThreeFold Sensors was acquired by Illumina to enhance its multi-omics portfolio and accelerate the development of protein-based diagnostic tools. The integration of this technology allows for the simultaneous analysis of DNA, RNA, and proteins, providing a more holistic view of biology. The company was founded by pioneers in the field of biosensing from the University of Toronto and Northwestern University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ThreeFold Sensors.